As of June 13, 2025, Arch Therapeutics Inc (ARTH) reports a Forward P/E of 0.01.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Arch Therapeutics Inc's Forward P/E to Peers
To better understand Arch Therapeutics Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Arch Therapeutics Inc (ARTH) | 0.01 |
| Antares Pharma Inc (ATRS) | 51.85 |
Compared to its competitors, Arch Therapeutics Inc's Forward P/E is lower than all peers, which may suggest undervaluation or market concerns about future earnings.